LYP6:XETRA:XETRA-Amundi Stoxx Europe 600 UCITS ETF C EUR (EUR)

ETF | Others |

Last Closing

USD 243.7

Change

-2.40 (-0.98)%

Market Cap

USD 7.39B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.12 (-0.08%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.10%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.11 (-0.22%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.27 (-0.28%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.66 (-0.12%)

USD 80.38B

ETFs Containing LYP6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.64% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.64% 59% D- 60% D-
Trailing 12 Months  
Capital Gain 20.55% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.55% 63% D 64% D
Trailing 5 Years  
Capital Gain 58.43% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.43% 72% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.70% N/A N/A 71% C-
Dividend Return 10.70% N/A N/A 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.90% N/A N/A 53% F
Risk Adjusted Return 76.95% N/A N/A 80% B-
Market Capitalization 7.39B 98% N/A 87% B+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike